Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation

Lupus

Volumn 23, Issue 12, 2014, Pages 1252-1254

  Forastiero, R ^a  

^a FAVALORO UNIVERSITY   (Argentina)

Author keywords

Antiphospholipid antibodies; antiphospholipid syndrome; pregnancy morbidity; thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PROTHROMBIN ANTIBODY; BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CONFERENCE PAPER; HIGH RISK PATIENT; HUMAN; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; VEIN THROMBOSIS; BLOOD; FEMALE; IMMUNOLOGY; PREGNANCY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; PREGNANCY;

EID: 84908696391     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314531635     Document Type: Conference Paper

References (10)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Forastiero R, Papalardo E, Watkins M, et al. Evaluation of different immunoassays for the detection of antiphospholipidantibodies: Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta. 2014 ; 428: 99-105
3. Hernández-Molina G, Espericueta-Arriola G, Cabral AR. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol. 2013 ; 31: 382-388
4. Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010 ; 8: 237-242
5. Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: A multicenter prospective study. Blood. 2011 ; 118: 4714-4718
6. Forastiero R, Martinuzzo M, Pombo G, et al. A prospective study of antibodies to β2 glycoprotein I and prothrombin and risk of thrombosis. J Thromb Haemost. 2005 ; 3: 1231-1238
7. Bizzaro N, Ghirardello A, Zampieri S, et al. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: A 15-year longitudinal study. J Thromb Haemost. 2007 ; 5: 1158-1164
8. Sciascia S, Murru V, Sanna G, et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: Evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost. 2012 ; 10: 2512-2518
9. Pengo V, Banzato A, Denas G, et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev. 2013 ; 12: 832-834
10. Pengo V, Banzato A, Bison E, et al. Antiphospholipid syndrome: Critical analysis of the diagnostic path. Lupus. 2010 ; 19: 428-431